These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 23563030

  • 21. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease.
    Matsuguma K, Ueda S, Yamagishi S, Matsumoto Y, Kaneyuki U, Shibata R, Fujimura T, Matsuoka H, Kimoto M, Kato S, Imaizumi T, Okuda S.
    J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406
    [Abstract] [Full Text] [Related]

  • 22. Estradiol, acting through estrogen receptor alpha, restores dimethylarginine dimethylaminohydrolase activity and nitric oxide production in oxLDL-treated human arterial endothelial cells.
    Novella S, Laguna-Fernández A, Lázaro-Franco M, Sobrino A, Bueno-Betí C, Tarín JJ, Monsalve E, Sanchís J, Hermenegildo C.
    Mol Cell Endocrinol; 2013 Jan 05; 365(1):11-6. PubMed ID: 22982060
    [Abstract] [Full Text] [Related]

  • 23. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
    Milewski K, Bogacińska-Karaś M, Fręśko I, Hilgier W, Jaźwiec R, Albrecht J, Zielińska M.
    Int J Mol Sci; 2017 Nov 02; 18(11):. PubMed ID: 29099056
    [Abstract] [Full Text] [Related]

  • 24. Effect of quercetin-5'-sulfonic acid sodium salt on SOD activity and ADMA/DDAH pathway in extracorporeal liver perfusion in rats.
    Trocha M, Merwid-Lad A, Szuba A, Sozański T, Magdalan J, Szelag A, Kopacz M, Kuźniar A, Nowak D.
    Adv Clin Exp Med; 2012 Nov 02; 21(4):423-31. PubMed ID: 23240447
    [Abstract] [Full Text] [Related]

  • 25. all-trans-Retinoic acid increases nitric oxide synthesis by endothelial cells: a role for the induction of dimethylarginine dimethylaminohydrolase.
    Achan V, Tran CT, Arrigoni F, Whitley GS, Leiper JM, Vallance P.
    Circ Res; 2002 Apr 19; 90(7):764-9. PubMed ID: 11964368
    [Abstract] [Full Text] [Related]

  • 26. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 19; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 27. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):32-41. PubMed ID: 17825631
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    Wetzel MD, Gao T, Stanley K, Cooper TK, Morris SM, Awad AS.
    Am J Physiol Renal Physiol; 2020 Feb 01; 318(2):F509-F517. PubMed ID: 31904280
    [Abstract] [Full Text] [Related]

  • 30. CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway.
    Zheng ZZ, Tian Fu X, Liang J, Bing Guo Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec 01; 159(4):540-6. PubMed ID: 25732979
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q, Peng J, Liu SY, Wang CJ, Xiang DX, Xiong XM, Hu CP, Li YJ.
    Clin Exp Pharmacol Physiol; 2010 May 01; 37(5-6):630-5. PubMed ID: 20132235
    [Abstract] [Full Text] [Related]

  • 34. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.
    Zhao Y, Ma X, Zhou Y, Xie J, Liu X, Zhao Y.
    Lab Invest; 2021 Jul 01; 101(7):808-823. PubMed ID: 33574439
    [Abstract] [Full Text] [Related]

  • 35. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
    Osorio-Yáñez C, Chin-Chan M, Sánchez-Peña LC, Atzatzi-Aguilar OG, Olivares-Reyes JA, Segovia J, Del Razo LM.
    Toxicol In Vitro; 2017 Aug 01; 42():281-286. PubMed ID: 28502835
    [Abstract] [Full Text] [Related]

  • 36. Endogenous Asymmetric Dimethylarginine Pathway in High Altitude Adapted Yaks.
    Mizuno S, Ishizaki T, Toga H, Sakai A, Isakova J, Taalaibekova E, Baiserkeev Z, Kojonazarov B, Aldashev A.
    Biomed Res Int; 2015 Aug 01; 2015():196904. PubMed ID: 26380264
    [Abstract] [Full Text] [Related]

  • 37. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase.
    Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T.
    Circ Res; 2003 Feb 07; 92(2):226-33. PubMed ID: 12574151
    [Abstract] [Full Text] [Related]

  • 38. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
    Buijs N, Oosterink JE, Jessup M, Schierbeek H, Stolz DB, Houdijk AP, Geller DA, van Leeuwen PA.
    Angiogenesis; 2017 Nov 07; 20(4):557-565. PubMed ID: 28741166
    [Abstract] [Full Text] [Related]

  • 39. Role of dimethylarginine dimethylaminohydrolase activity in regulation of tissue and plasma concentrations of asymmetric dimethylarginine in an animal model of prolonged critical illness.
    Davids M, Richir MC, Visser M, Ellger B, van den Berghe G, van Leeuwen PA, Teerlink T.
    Metabolism; 2012 Apr 07; 61(4):482-90. PubMed ID: 22000584
    [Abstract] [Full Text] [Related]

  • 40. Role of ADMA/DDAH-1 and iNOS/eNOS signaling in the gastroprotective effect of tadalafil against indomethacin-induced gastric injury.
    Mohamed YT, Naguib IA, Abo-Saif AA, Elkomy MH, Alghamdi BS, Mohamed WR.
    Biomed Pharmacother; 2022 Jun 07; 150():113026. PubMed ID: 35658250
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.